SIncalide (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the SIncalide drug offered from AnazaoHealth Corporation. This Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | Sincalide |
SUBSTANCE NAME: | SINCALIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
SIncalide HUMAN PRESCRIPTION DRUG Details:
Item Description | SIncalide from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(ug/1) |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-203_8f9023fb-e982-440a-a9ee-374c4bf3153b |
PRODUCT NDC: | 51808-203 |
APPLICATION NUMBER: | |
Other SINCALIDE Pharmaceutical Manufacturers / Labelers: